Literature DB >> 32594835

Low expression of miR-let-7a promotes cell growth and invasion through the regulation of c-Myc in oral squamous cell carcinoma.

Chunyang Luo1, Jiyong Zhang1, Yi Zhang1, Xiao Zhang1, Yinan Chen2, Weimin Fan1.   

Abstract

In oral squamous cell carcinoma (OSCC), abnormal expression of microRNAs has been extensively reported. MiR-let-7a has been validated as a critical regulator of multiple cancers, but the biological process involved and its potential role in OSCC remain unknown.We first analyzed the differential expression of miR-let-7a in cancer tissues, adjacent noncancerous tissues and cell lines. The functional role of miR-let-7a in OSCC cell lines was evaluated by using colony formation assays, cell proliferation and transwell invasion assays in vitro. In addition, subcutaneous xenotransplantation of miR-let-7a transfected cells into nude mouse model was carried out to explore the potential function of miR-let-7a in vivo.miR-let-7a levels were found to be significantly downregulated in OSCC tissues compared with matched normal tissues (n = 60), and lower expression of miR-let-7a was related to poor prognosis in OSCC patients. Overexpression of MiR-let-7a induced a suppression in proliferation, invasion and migration and inhibited tumourigenesis in the nude mouse model. We also determined that c-Myc may serve as a direct target of miR-let-7a; furthermore, upregulated c-Myc expression could partially rescue the effects caused by miR-let-7a overexpression. miR-let-7a is low expression in OSCC, and promotes tumor development by directly targeting c-Myc. Our results may provide a potential therapeutic role for miR-let-7a in human OSCC.

Entities:  

Keywords:  OSCC; invasion; miR-let-7a; migration; proliferation

Year:  2020        PMID: 32594835      PMCID: PMC7469679          DOI: 10.1080/15384101.2020.1786633

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  44 in total

1.  Tumor-suppressive microRNA-let-7a inhibits cell proliferation via targeting of E2F2 in osteosarcoma cells.

Authors:  Tatsuya Iwasaki; Kazuhiro Tanaka; Masanori Kawano; Ichiro Itonaga; Hiroshi Tsumura
Journal:  Int J Oncol       Date:  2015-02-03       Impact factor: 5.650

Review 2.  The myc family of nuclear proto-oncogenes.

Authors:  W M Lee
Journal:  Cancer Treat Res       Date:  1989

3.  Transcriptional amplification in tumor cells with elevated c-Myc.

Authors:  Charles Y Lin; Jakob Lovén; Peter B Rahl; Ronald M Paranal; Christopher B Burge; James E Bradner; Tong Ihn Lee; Richard A Young
Journal:  Cell       Date:  2012-09-28       Impact factor: 41.582

4.  Lack of sustained regression of c-MYC-induced mammary adenocarcinomas following brief or prolonged MYC inactivation.

Authors:  Robert B Boxer; Joanne W Jang; Louis Sintasath; Lewis A Chodosh
Journal:  Cancer Cell       Date:  2004-12       Impact factor: 31.743

5.  Downregulation of lncRNA ANRIL represses tumorigenicity and enhances cisplatin-induced cytotoxicity via regulating microRNA let-7a in nasopharyngeal carcinoma.

Authors:  Yandan Wang; Nan Cheng; Junpeng Luo
Journal:  J Biochem Mol Toxicol       Date:  2017-01-24       Impact factor: 3.642

Review 6.  MYC, Metabolism, and Cancer.

Authors:  Zachary E Stine; Zandra E Walton; Brian J Altman; Annie L Hsieh; Chi V Dang
Journal:  Cancer Discov       Date:  2015-09-17       Impact factor: 39.397

Review 7.  MicroRNAs in human cancer.

Authors:  Thalia A Farazi; Jessica I Hoell; Pavel Morozov; Thomas Tuschl
Journal:  Adv Exp Med Biol       Date:  2013       Impact factor: 2.622

8.  Cancer treatment and survivorship statistics, 2016.

Authors:  Kimberly D Miller; Rebecca L Siegel; Chun Chieh Lin; Angela B Mariotto; Joan L Kramer; Julia H Rowland; Kevin D Stein; Rick Alteri; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2016-06-02       Impact factor: 508.702

9.  The let-7a microRNA protects from growth of lung carcinoma by suppression of k-Ras and c-Myc in nude mice.

Authors:  Xiao-Yan He; Jun-xia Chen; Zheng Zhang; Chun-lei Li; Qiong-le Peng; Hui-min Peng
Journal:  J Cancer Res Clin Oncol       Date:  2009-12-22       Impact factor: 4.553

10.  The microRNA.org resource: targets and expression.

Authors:  Doron Betel; Manda Wilson; Aaron Gabow; Debora S Marks; Chris Sander
Journal:  Nucleic Acids Res       Date:  2007-12-23       Impact factor: 16.971

View more
  5 in total

Review 1.  Research progress and clinical application prospects of miRNAs in oral cancer.

Authors:  Long Xing; Zhenghu Feng; Hongbing Nie; Meitian Liu; Yali Liu; Xiaohua Zhang; Haijing Zhou
Journal:  Mol Biol Rep       Date:  2022-06-20       Impact factor: 2.316

2.  MicroRNA-124-3p-enriched small extracellular vesicles as a therapeutic approach for Parkinson's disease.

Authors:  Marta Esteves; Ricardo Abreu; Hugo Fernandes; Catarina Serra-Almeida; Patrícia A T Martins; Marta Barão; Ana Clara Cristóvão; Cláudia Saraiva; Raquel Ferreira; Lino Ferreira; Liliana Bernardino
Journal:  Mol Ther       Date:  2022-06-09       Impact factor: 12.910

3.  Upregulated microRNA let-7a accelerates apoptosis and inhibits proliferation in uterine junctional zone smooth muscle cells in adenomyosis under conditions of a normal activated hippo-YAP1 axis.

Authors:  Jun-Hua Huang; Hua Duan; Sha Wang; Yi-Yi Wang; Cheng-Xiao Lv
Journal:  Reprod Biol Endocrinol       Date:  2021-06-03       Impact factor: 5.211

4.  Identification and validation of transcription factor-driven enhancers of genes related to lipid metabolism in metastatic oral squamous cell carcinomas.

Authors:  Liru Zhang; Shuangling Zhao; Yuanhang Liu; Feifei Lv; Xixue Geng
Journal:  BMC Oral Health       Date:  2022-04-15       Impact factor: 3.747

Review 5.  Promising Biomarkers in Head and Neck Cancer: The Most Clinically Important miRNAs.

Authors:  Arsinoe C Thomaidou; Panagiota Batsaki; Maria Adamaki; Maria Goulielmaki; Constantin N Baxevanis; Vassilis Zoumpourlis; Sotirios P Fortis
Journal:  Int J Mol Sci       Date:  2022-07-26       Impact factor: 6.208

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.